Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 10

Zeitschriftenartikel

Dempke, Wolfram C. M. und Fenchel, Klaus (2021): Has programmed cell death ligand-1 MET an accomplice in non-small cell lung cancer?-a narrative review. In: Translational Lung Cancer Research, Bd. 10, Nr. 6: S. 2667-2682

Dempke, Wolfram C. M. und Reck, Martin (2021): KEAP1/NRF2 (NFE2L2) mutations in NSCLC-Fuel for a superresistant phenotype? In: Lung Cancer, Bd. 159: S. 10-17

Wang, Yanhui; Xiao, Jiawei; Jiang, Wenna; Zuo, Duo; Wang, Xia; Jin, Yu; Qiao, Lu; An, Haohua; Yang, Lexin; Dumoulin, Daphne W.; Dempke, Wolfram C. M.; Best, Sarah A. und Ren, Li (2021): BCKDK alters the metabolism of non-small cell lung cancer. In: Translational Lung Cancer Research, Bd. 10, Nr. 12: S. 4459-4476

Uciechowski, Peter und Dempke, Wolfram C. M. (2020): Interleukin-6: A Masterplayer in the Cytokine Network. In: Oncology, Bd. 98, Nr. 3: S. 131-137

Manz, Kirsi M. ORCID logoORCID: https://orcid.org/0000-0002-7740-4076; Fenchel, Klaus; Eilers, Andreas; Morgan, Jonathan; Wittling, Kirsten und Dempke, Wolfram C. M. ORCID logoORCID: https://orcid.org/0000-0002-7683-1017 (14. Dezember 2019): Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis. In: Advances in therapy, Bd. 37: S. 730-744 [PDF, 1MB]

Dempke, Wolfram C. M.; Fenchel, Klaus; Uciechowski, Peter und Dale, Stephen P. (2017): Second- and third-generation drugs for immuno-oncology treatment-The more the better? In: European Journal of Cancer, Bd. 74: S. 55-72

Dempke, Wolfram C. M.; Fenchel, Klaus; Uciechowski, Peter und Chevassut, Timothy (2017): Targeting Developmental Pathways: The Achilles Heel of Cancer? In: Oncology, Bd. 93, Nr. 4: S. 213-223

Fenchel, Klaus; Dale, Stephen P. und Dempke, Wolfram C. M. (2016): Improved overall survival following tyrosine kinase inhibitor (TKI) treatment in NSCLC-are we making progress? In: Translational Lung Cancer Research, Bd. 5, Nr. 4: S. 373-376

Dempke, Wolfram C. M. und Fenchel, Klaus (2016): Pembrolizumab as first-line treatment for non-small cell lung cancer-a game changer? In: Translational Lung Cancer Research, Bd. 5, Nr. 5: S. 538-542

Fenchel, Klaus; Sellmann, Ludger und Dempke, Wolfram C. M. (2016): Overall survival in non-small cell lung cancer-what is clinically meaningful? In: Translational Lung Cancer Research, Bd. 5, Nr. 1: S. 115-119

Diese Liste wurde am Sat Mar 23 22:50:06 2024 CET erstellt.